Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents

Bioorg Med Chem Lett. 2016 Aug 15;26(16):4015-9. doi: 10.1016/j.bmcl.2016.06.087. Epub 2016 Jul 1.

Abstract

A series of N(9)-substituted harmine derivatives were synthesized and evaluated for their anticancer activity on a panel of cancer cell lines, their apoptosis induction and their cell cycle effects. The results showed that N(9)-substituted harmine derivatives had anticancer effects. In particular, N(9)-haloalkyl derivatives 9a-9c and N(9)-acyl harmine derivatives 11c and 11d, with IC50 values less than 1μM, were more potent than doxorubicin against A-549 and/or MCF-7 cell lines. Moreover, structure-activity relationships (SARs) indicated that introducing a haloalkyl or benzenesulfonyl group in the N(9)-position of harmine could significantly increase the anticancer activity. The most active compound (11d) caused cell cycle arrest in the G2/M phase, and induced cell apoptosis in a dose-dependent manner.

Keywords: Anticancer activities; Apoptosis; Cell cycle arrest; Harmine derivatives; Structure–activity relationships (SARs).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / toxicity
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • G2 Phase Cell Cycle Checkpoints / drug effects
  • Harmine / chemical synthesis
  • Harmine / chemistry*
  • Harmine / toxicity
  • Humans
  • M Phase Cell Cycle Checkpoints / drug effects
  • MCF-7 Cells
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Harmine